Exuma Biotech Corp.

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

• GFGregory FrostDirector · Executive Officer
• FMFrank McCormickDirector
• DRDavid RamsayDirector
• SSScott SegalDirector
• JSJay ShortDirector

• 31 Mar 2026Methods And Compositions For Genetically Modifying And Expanding Lymphocytes And Regulating The Activity Thereofgranted
• 24 Jul 2025Methods And Compositions For Transducing Lymphocytes And Regulating The Activity Thereofapplication
• 10 Jun 2025Methods And Compositions For Genetically Modifying Lymphocytes To Express Polypeptides Comprising The Intracellular Domain Of CD79A And CD79Bgranted
• 27 Mar 2025Viral Particles With Membrane-bound Hyaluronidaseapplication
• 25 Mar 2025Methods And Compositions For Transducing Lymphocytes And Regulating The Activity Thereofgranted
• 07 Dec 2023Methods And Compositions For Transducing And Expanding Lymphocytes And Regulating The Activity Thereofapplication
• 09 Nov 2023Anti-idiotype Compositions And Methods Of Use Thereofapplication
• 17 Aug 2023Methods And Compositions For Transducing Lymphocytes And Regulating The Activity Thereofapplication
• 13 Apr 2023Methods And Compositions For The Delivery Of Modified Lymphocyte Aggregatesapplication
• 09 Feb 2023Methods And Compositions For The Delivery Of Modified Lymphocytes And/or Retroviral Particlesapplication
• 27 Oct 2022Methods And Compositions For The Modification And Delivery Of Lymphocytesapplication
• 10 May 2022Methods And Compositions For Genetically Modifying Lymphocytes To Express Polypeptides Comprising The Intracellular Domain Of Mplgranted

• 07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
• 30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
• 30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
• 29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
• 26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
• 26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.